144. レノックス・ガストー症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 128 / 薬物数 : 53 - (DrugBank : 13) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 62
薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
12-lead ECG
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
ANY other approved antiepileptic drug
Eisai Inc.
2011 Phase 3 NCT01405053 Canada;France;Greece;India;Italy;Poland;South Africa;United States
BMB-101
Bright Minds Biosciences Pty Ltd
2024 Phase 2 NCT06401538 Australia
Cannabidiol
GW Research Ltd
2015 Phase 3 EUCTR2014-002940-42-GB France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002940-42-ES France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
GW Research Ltd.
2015 Phase 3 EUCTR2014-002941-23-PL Netherlands;Poland;United States
2015 - EUCTR2014-002941-23-NL Netherlands;Poland;United States
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
Jazz Pharmaceuticals
2021 Phase 4 NCT05044819 United States
Yonsei University
2020 Phase 3 NCT04611438 Korea, Republic of
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States
Cannabidiol oral solution
INSYS Therapeutics Inc
2017 Phase 3 NCT02318537 -
Carisbamate
SK Life Science, Inc.
2022 Phase 3 NCT05219617 Argentina;Australia;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2019 Phase 1 NCT04062981 United States
2019 Phase 1 NCT03731715 United States
Carisbamate (S)-2-O-carbamoyl-1-O-chlorophenyl-ethanol
SK Life Science, Inc
2023 Phase 3 EUCTR2022-001256-42-PT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-PL Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-HU Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-GR Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-DE Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
Sk Life Science Inc.
2023 Phase 3 EUCTR2022-001256-42-IT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
CBD
GW Research Ltd
2015 Phase 3 EUCTR2014-002940-42-GB France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002940-42-ES France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
GW Research Ltd.
2015 Phase 3 EUCTR2014-002941-23-PL Netherlands;Poland;United States
2015 - EUCTR2014-002941-23-NL Netherlands;Poland;United States
CBD: GT4 transdermal delivery system
Alexander Rotenberg
2025 Phase 1/Phase 2 NCT06738732 United States
Clemizole HCL
Epygenix
2025 Phase 3 NCT05066217 United States
Clobazam
Lundbeck LLC
2005 Phase 3 NCT01160770 -
Clobazam high dose
Lundbeck LLC
2007 Phase 3 NCT00518713 Australia;Belarus;India;Lithuania;Serbia;United States
2005 Phase 2 NCT00162981 United States
Clobazam LOW dose
Lundbeck LLC
2007 Phase 3 NCT00518713 Australia;Belarus;India;Lithuania;Serbia;United States
2005 Phase 2 NCT00162981 United States
Clobazam medium dose
Lundbeck LLC
2007 Phase 3 NCT00518713 Australia;Belarus;India;Lithuania;Serbia;United States
Clobazam tablets 10MG
Lundbeck Inc
2008 - EUCTR2007-004350-82-LT Bulgaria;Lithuania
Ovation Pharmaceuticals
2008 - EUCTR2007-004350-82-BG Bulgaria;Lithuania
Clobazam tablets 20MG
Lundbeck Inc
2008 - EUCTR2007-004350-82-LT Bulgaria;Lithuania
Ovation Pharmaceuticals
2008 - EUCTR2007-004350-82-BG Bulgaria;Lithuania
Clobazam tablets 5MG
Lundbeck Inc
2008 - EUCTR2007-004350-82-LT Bulgaria;Lithuania
2008 - EUCTR2007-004322-24-LT Bulgaria;Lithuania
Ovation Pharmaceuticals
2008 - EUCTR2007-004350-82-BG Bulgaria;Lithuania
Ovation Pharmaceuticals Inc.
2008 - EUCTR2007-004322-24-BG Bulgaria;Lithuania
E2007
EISAI LIMITED
2017 Phase 3 EUCTR2014-002321-35-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Poland;United States
Eisai Co., Ltd.
2016 Phase 3 JPRN-jRCT2080223481 Asia except Japan;Europe;Japan;North America;Oceania
Eisai Limited
2018 Phase 3 EUCTR2014-002321-35-BE Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-LV Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-HU Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-CZ Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-PL Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-FR Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
E2080
Eisai Co, Ltd.
- Phase 3 EUCTR2016-004953-34-Outside-EU/EEA Japan
- Phase 3 EUCTR2016-004952-30-Outside-EU/EEA Japan
Eisai Limited
2010 Phase 3 NCT01146951 Japan
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Epidiolex 100 MG/ML oral solution
Elizabeth Donner
2025 Phase 4 NCT06924827 Canada
Jazz Pharmaceuticals
2025 - NCT05485831 Italy
Ezogabine/retigabine
GlaxoSmithKline
2012 Phase 2 NCT01494584 United States
Fenfluramina cloridrato
Zogenix International Limited
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Fenfluramine
KU Leuven
2016 Phase 2 NCT02655198 Belgium
Fenfluramine HCL, DL-fenfluramine, (±)-fenfluramine
Zogenix International Inc.
2018 Phase 3 EUCTR2017-002628-26-IT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited
2018 Phase 3 EUCTR2017-002628-26-ES Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2019 Phase 3 EUCTR2017-002628-26-SE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-FR Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-BE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-PL Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-GB Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-AT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Fenfluramine hydrochloride
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200096 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Mexico;Netherland;Poland;Spain;Sweeden;US
Zogenix International Inc.
2018 Phase 3 EUCTR2017-002628-26-IT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-ES Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2019 Phase 3 EUCTR2017-002628-26-SE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-FR Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-BE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-PL Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-GB Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-AT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Fycompa
EISAI LIMITED
2017 Phase 3 EUCTR2014-002321-35-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Poland;United States
Eisai Limited
2018 Phase 3 EUCTR2014-002321-35-BE Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-LV Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-HU Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-CZ Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-PL Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-FR Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
GW582892
GlaxoSmithKline R&D Limited
- - EUCTR2012-001132-60-Outside-EU/EEA United States
- - EUCTR2010-020154-33-Outside-EU/EEA United States
GWP42003-P
GW Research Ltd
2015 Phase 3 NCT02224573 -
2015 Phase 3 EUCTR2014-002940-42-GB France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002940-42-ES France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
GW Research Ltd.
2015 Phase 3 EUCTR2014-002941-23-PL Netherlands;Poland;United States
2015 - EUCTR2014-002941-23-NL Netherlands;Poland;United States
Jazz Pharmaceuticals
2021 Phase 3 NCT04485104 Italy;Spain;United States
2020 Phase 4 NCT04133480 United States
2015 Phase 3 NCT02224560 France;Spain;United Kingdom;United States
GWP42003-P 20 MG/KG/DAY dose
Jazz Pharmaceuticals
2015 Phase 3 NCT02224690 Netherlands;Poland;United States
Inovelon
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Eisai Co, Ltd.
- Phase 3 EUCTR2016-004953-34-Outside-EU/EEA Japan
- Phase 3 EUCTR2016-004952-30-Outside-EU/EEA Japan
Eisai Co., Ltd.
2013 - JPRN-jRCT1080222123 Japan
Investigators choice OF approved AED
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Investigators choice OF approved aeds
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Lamictal
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Lamotrigine
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
LP352
Longboard Pharmaceuticals
2024 - NCT06149663 Australia;United States
2022 Phase 1/Phase 2 NCT05364021 Australia;United States
LP352, bexicaserin
Longboard Pharmaceuticals
2022 Phase 2 NCT05626634 Australia;United States
MIC
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210073 Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Korea;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
Perampanel
EISAI LIMITED
2017 Phase 3 EUCTR2014-002321-35-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Poland;United States
Eisai Co., Ltd.
2016 Phase 3 JPRN-jRCT2080223481 Asia except Japan;Europe;Japan;North America;Oceania
Eisai Inc.
2016 Phase 3 NCT02834793 Australia;Austria;Belgium;Czechia;India;Japan;Korea, Republic of;United States
2014 - NCT02307578 Belgium;Chile;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Serbia;Spain
Eisai Limited
2018 Phase 3 EUCTR2014-002321-35-BE Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-LV Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-HU Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-CZ Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-PL Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-FR Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
Potiga
GlaxoSmithKline R&D Limited
- - EUCTR2012-001132-60-Outside-EU/EEA United States
- - EUCTR2010-020154-33-Outside-EU/EEA United States
Retigabine/ezogabine
GlaxoSmithKline
2012 Phase 3 NCT01668654 United States
GlaxoSmithKline R&D Limited
- - EUCTR2012-001132-60-Outside-EU/EEA United States
- - EUCTR2010-020154-33-Outside-EU/EEA United States
Rufinamide
Eisai Co, Ltd.
- Phase 3 EUCTR2016-004953-34-Outside-EU/EEA Japan
- Phase 3 EUCTR2016-004952-30-Outside-EU/EEA Japan
Eisai Co., Ltd.
2013 - NCT02175173 Japan
2013 - JPRN-jRCT1080222123 Japan
2010 Phase 3 NCT01151540 Japan
Eisai Inc.
2021 - NCT03778424 Poland
2011 Phase 3 NCT01405053 Canada;France;Greece;India;Italy;Poland;South Africa;United States
Eisai Limited
2010 Phase 3 NCT01146951 Japan
Rufinamide oral suspension
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Sodio valproato
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Soticlestat
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210073 Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Korea;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2024 Phase 3 NCT06422377 Denmark;United Kingdom
2022 Phase 3 NCT05163314 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 NCT04938427 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2018 Phase 2 NCT03635073 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002481-40-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002481-40-Outside-EU/EEA Australia;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
- Phase 3 EUCTR2021-002481-40-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TAK-935
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2018 Phase 2 NCT03650452 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002481-40-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002481-40-Outside-EU/EEA Australia;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
- Phase 3 EUCTR2021-002481-40-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Topimarate
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Topimarato
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Topiramate
Janssen Cilag Pharmaceutica S.A.C.I., Greece
2003 - NCT00297349 -
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
1993 Phase 3 NCT00236756 -
National Center for Research Resources (NCRR)
1993 Phase 3 NCT00004776 -
Turmeric
NYU Langone Health
2018 - NCT03254680 United States
YKP509
SK Life Science, Inc
2023 Phase 3 EUCTR2022-001256-42-PT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-PL Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-HU Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-GR Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-DE Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
Sk Life Science Inc.
2023 Phase 3 EUCTR2022-001256-42-IT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
ZX008
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200096 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Mexico;Netherland;Poland;Spain;Sweeden;US
Zogenix International Inc.
2018 Phase 3 EUCTR2017-002628-26-IT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-ES Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2019 Phase 3 EUCTR2017-002628-26-SE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-FR Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-BE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-PL Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-GB Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-AT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
ZX008 0.2 or 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2017 Phase 3 NCT03355209 Australia;Austria;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United States
ZX008 0.2 TO 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
ANY other approved antiepileptic drug
Eisai Inc.
2011 Phase 3 NCT01405053 Canada;France;Greece;India;Italy;Poland;South Africa;United States
BMB-101
Bright Minds Biosciences Pty Ltd
2024 Phase 2 NCT06401538 Australia
Cannabidiol
GW Research Ltd
2015 Phase 3 EUCTR2014-002940-42-GB France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002940-42-ES France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
GW Research Ltd.
2015 Phase 3 EUCTR2014-002941-23-PL Netherlands;Poland;United States
2015 - EUCTR2014-002941-23-NL Netherlands;Poland;United States
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
Jazz Pharmaceuticals
2021 Phase 4 NCT05044819 United States
Yonsei University
2020 Phase 3 NCT04611438 Korea, Republic of
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States
Cannabidiol oral solution
INSYS Therapeutics Inc
2017 Phase 3 NCT02318537 -
Carisbamate
SK Life Science, Inc.
2022 Phase 3 NCT05219617 Argentina;Australia;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2019 Phase 1 NCT04062981 United States
2019 Phase 1 NCT03731715 United States
Carisbamate (S)-2-O-carbamoyl-1-O-chlorophenyl-ethanol
SK Life Science, Inc
2023 Phase 3 EUCTR2022-001256-42-PT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-PL Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-HU Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-GR Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-DE Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
Sk Life Science Inc.
2023 Phase 3 EUCTR2022-001256-42-IT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
CBD
GW Research Ltd
2015 Phase 3 EUCTR2014-002940-42-GB France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002940-42-ES France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
GW Research Ltd.
2015 Phase 3 EUCTR2014-002941-23-PL Netherlands;Poland;United States
2015 - EUCTR2014-002941-23-NL Netherlands;Poland;United States
CBD: GT4 transdermal delivery system
Alexander Rotenberg
2025 Phase 1/Phase 2 NCT06738732 United States
Clemizole HCL
Epygenix
2025 Phase 3 NCT05066217 United States
Clobazam
Lundbeck LLC
2005 Phase 3 NCT01160770 -
Clobazam high dose
Lundbeck LLC
2007 Phase 3 NCT00518713 Australia;Belarus;India;Lithuania;Serbia;United States
2005 Phase 2 NCT00162981 United States
Clobazam LOW dose
Lundbeck LLC
2007 Phase 3 NCT00518713 Australia;Belarus;India;Lithuania;Serbia;United States
2005 Phase 2 NCT00162981 United States
Clobazam medium dose
Lundbeck LLC
2007 Phase 3 NCT00518713 Australia;Belarus;India;Lithuania;Serbia;United States
Clobazam tablets 10MG
Lundbeck Inc
2008 - EUCTR2007-004350-82-LT Bulgaria;Lithuania
Ovation Pharmaceuticals
2008 - EUCTR2007-004350-82-BG Bulgaria;Lithuania
Clobazam tablets 20MG
Lundbeck Inc
2008 - EUCTR2007-004350-82-LT Bulgaria;Lithuania
Ovation Pharmaceuticals
2008 - EUCTR2007-004350-82-BG Bulgaria;Lithuania
Clobazam tablets 5MG
Lundbeck Inc
2008 - EUCTR2007-004350-82-LT Bulgaria;Lithuania
2008 - EUCTR2007-004322-24-LT Bulgaria;Lithuania
Ovation Pharmaceuticals
2008 - EUCTR2007-004350-82-BG Bulgaria;Lithuania
Ovation Pharmaceuticals Inc.
2008 - EUCTR2007-004322-24-BG Bulgaria;Lithuania
E2007
EISAI LIMITED
2017 Phase 3 EUCTR2014-002321-35-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Poland;United States
Eisai Co., Ltd.
2016 Phase 3 JPRN-jRCT2080223481 Asia except Japan;Europe;Japan;North America;Oceania
Eisai Limited
2018 Phase 3 EUCTR2014-002321-35-BE Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-LV Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-HU Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-CZ Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-PL Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-FR Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
E2080
Eisai Co, Ltd.
- Phase 3 EUCTR2016-004953-34-Outside-EU/EEA Japan
- Phase 3 EUCTR2016-004952-30-Outside-EU/EEA Japan
Eisai Limited
2010 Phase 3 NCT01146951 Japan
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Epidiolex 100 MG/ML oral solution
Elizabeth Donner
2025 Phase 4 NCT06924827 Canada
Jazz Pharmaceuticals
2025 - NCT05485831 Italy
Ezogabine/retigabine
GlaxoSmithKline
2012 Phase 2 NCT01494584 United States
Fenfluramina cloridrato
Zogenix International Limited
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Fenfluramine
KU Leuven
2016 Phase 2 NCT02655198 Belgium
Fenfluramine HCL, DL-fenfluramine, (±)-fenfluramine
Zogenix International Inc.
2018 Phase 3 EUCTR2017-002628-26-IT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited
2018 Phase 3 EUCTR2017-002628-26-ES Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2019 Phase 3 EUCTR2017-002628-26-SE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-FR Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-BE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-PL Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-GB Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-AT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Fenfluramine hydrochloride
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200096 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Mexico;Netherland;Poland;Spain;Sweeden;US
Zogenix International Inc.
2018 Phase 3 EUCTR2017-002628-26-IT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-ES Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2019 Phase 3 EUCTR2017-002628-26-SE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-FR Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-BE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-PL Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-GB Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-AT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Fycompa
EISAI LIMITED
2017 Phase 3 EUCTR2014-002321-35-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Poland;United States
Eisai Limited
2018 Phase 3 EUCTR2014-002321-35-BE Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-LV Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-HU Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-CZ Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-PL Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-FR Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
GW582892
GlaxoSmithKline R&D Limited
- - EUCTR2012-001132-60-Outside-EU/EEA United States
- - EUCTR2010-020154-33-Outside-EU/EEA United States
GWP42003-P
GW Research Ltd
2015 Phase 3 NCT02224573 -
2015 Phase 3 EUCTR2014-002940-42-GB France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002940-42-ES France;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
GW Research Ltd.
2015 Phase 3 EUCTR2014-002941-23-PL Netherlands;Poland;United States
2015 - EUCTR2014-002941-23-NL Netherlands;Poland;United States
Jazz Pharmaceuticals
2021 Phase 3 NCT04485104 Italy;Spain;United States
2020 Phase 4 NCT04133480 United States
2015 Phase 3 NCT02224560 France;Spain;United Kingdom;United States
GWP42003-P 20 MG/KG/DAY dose
Jazz Pharmaceuticals
2015 Phase 3 NCT02224690 Netherlands;Poland;United States
Inovelon
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Eisai Co, Ltd.
- Phase 3 EUCTR2016-004953-34-Outside-EU/EEA Japan
- Phase 3 EUCTR2016-004952-30-Outside-EU/EEA Japan
Eisai Co., Ltd.
2013 - JPRN-jRCT1080222123 Japan
Investigators choice OF approved AED
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Investigators choice OF approved aeds
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Lamictal
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Lamotrigine
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
LP352
Longboard Pharmaceuticals
2024 - NCT06149663 Australia;United States
2022 Phase 1/Phase 2 NCT05364021 Australia;United States
LP352, bexicaserin
Longboard Pharmaceuticals
2022 Phase 2 NCT05626634 Australia;United States
MIC
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210073 Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Korea;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
Perampanel
EISAI LIMITED
2017 Phase 3 EUCTR2014-002321-35-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Poland;United States
Eisai Co., Ltd.
2016 Phase 3 JPRN-jRCT2080223481 Asia except Japan;Europe;Japan;North America;Oceania
Eisai Inc.
2016 Phase 3 NCT02834793 Australia;Austria;Belgium;Czechia;India;Japan;Korea, Republic of;United States
2014 - NCT02307578 Belgium;Chile;Czechia;Estonia;Hungary;Latvia;Lithuania;Poland;Serbia;Spain
Eisai Limited
2018 Phase 3 EUCTR2014-002321-35-BE Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-LV Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-HU Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
2017 Phase 3 EUCTR2014-002321-35-CZ Australia;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-PL Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
- Phase 3 EUCTR2014-002321-35-FR Australia;Belgium;Canada;Czech Republic;France;Hungary;Italy;Japan;Korea, Republic of;Latvia;Poland;United States
Potiga
GlaxoSmithKline R&D Limited
- - EUCTR2012-001132-60-Outside-EU/EEA United States
- - EUCTR2010-020154-33-Outside-EU/EEA United States
Retigabine/ezogabine
GlaxoSmithKline
2012 Phase 3 NCT01668654 United States
GlaxoSmithKline R&D Limited
- - EUCTR2012-001132-60-Outside-EU/EEA United States
- - EUCTR2010-020154-33-Outside-EU/EEA United States
Rufinamide
Eisai Co, Ltd.
- Phase 3 EUCTR2016-004953-34-Outside-EU/EEA Japan
- Phase 3 EUCTR2016-004952-30-Outside-EU/EEA Japan
Eisai Co., Ltd.
2013 - NCT02175173 Japan
2013 - JPRN-jRCT1080222123 Japan
2010 Phase 3 NCT01151540 Japan
Eisai Inc.
2021 - NCT03778424 Poland
2011 Phase 3 NCT01405053 Canada;France;Greece;India;Italy;Poland;South Africa;United States
Eisai Limited
2010 Phase 3 NCT01146951 Japan
Rufinamide oral suspension
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Eisai Ltd
2012 - EUCTR2010-023505-36-GR Greece;Italy;South Africa;United States
- Phase 3 EUCTR2010-023505-36-Outside-EU/EEA Canada;United States
- Phase 3 EUCTR2010-023505-36-FR France;Greece;India;Italy;United States
Sodio valproato
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Soticlestat
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210073 Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Korea;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2024 Phase 3 NCT06422377 Denmark;United Kingdom
2022 Phase 3 NCT05163314 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 NCT04938427 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2018 Phase 2 NCT03635073 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002481-40-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002481-40-Outside-EU/EEA Australia;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
- Phase 3 EUCTR2021-002481-40-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
TAK-935
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2018 Phase 2 NCT03650452 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002481-40-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002481-40-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002481-40-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002481-40-Outside-EU/EEA Australia;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
- Phase 3 EUCTR2021-002481-40-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Topimarate
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Topimarato
EISAI LTD UK
2011 - EUCTR2010-023505-36-IT Greece;Italy
Topiramate
Janssen Cilag Pharmaceutica S.A.C.I., Greece
2003 - NCT00297349 -
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
1993 Phase 3 NCT00236756 -
National Center for Research Resources (NCRR)
1993 Phase 3 NCT00004776 -
Turmeric
NYU Langone Health
2018 - NCT03254680 United States
YKP509
SK Life Science, Inc
2023 Phase 3 EUCTR2022-001256-42-PT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-PL Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-HU Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-GR Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
2023 Phase 3 EUCTR2022-001256-42-DE Australia;Colombia;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
Sk Life Science Inc.
2023 Phase 3 EUCTR2022-001256-42-IT Argentina;Colombia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Mexico;Poland;Portugal;Serbia;Spain;Taiwan;United States
ZX008
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200096 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Mexico;Netherland;Poland;Spain;Sweeden;US
Zogenix International Inc.
2018 Phase 3 EUCTR2017-002628-26-IT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-ES Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2019 Phase 3 EUCTR2017-002628-26-SE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-FR Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-DE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
2018 Phase 3 EUCTR2017-002628-26-BE Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-PL Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-GB Australia;Austria;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2017-002628-26-AT Australia;Austria;Belgium;Canada;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
ZX008 0.2 or 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2017 Phase 3 NCT03355209 Australia;Austria;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United States
ZX008 0.2 TO 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States